Джон Макдугалл - Энергия крахмала. Ешьте вкусно, заботьтесь о здоровье и худейте навсегда

Bjelakovic G, Gluud C. Vitamin and mineral supplement use in relation to all-cause mortality in the Iowa Women’s Health Study. Arch Intern Med. 2011 Oct 10; 171 (18): 1633–34.

Redberg RF. Vitamin supplements: more cost than value: comment on “dietary supplements and mortality rate in older women.” Arch Intern Med. 2011 Oct 10; 171 (18): 1634–35.

Lee JE, Chan AT. Fruit, vegetables, and folate: cultivating the evidence for cancer prevention. Gastroenterolog y. 2011 Jul; 141 (1): 16–20.

Pietrzik K. Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med. 1996 Oct 3; 335 (14): 1065–66.

Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009; 301: 39–51.

Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011 Oct 12; 306 (14): 1549–56.

Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 Jul 6; 360 (9326): 23–33.

Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and betacarotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997 Jun 14; 349 (9067): 1715–20.

Mursu J, Robien K, Harnack LJ, et al. Dietary Supplements and Mortality Rate in Older Women: The Iowa Women’s Health Study. Arch Intern Med. 2011 Oct 10; 171 (18): 1625–33.

Lonn E, Bosch J, Yusuf S, et al; HOPE and HOPE-TOO Trial Investigators. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005 Mar 16; 293 (11): 1338–47.

Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004 Jun 24; 350 (26): 2673–81.

Bønaa KH, Njølstad I, Ueland PM, et al; NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006 Apr 13; 354 (15): 1578–88.

Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008 May 7; 299 (17): 2027–36.

Durga J, Bots ML, Schouten EG, et al. Effect of 3 y of folic acid supplementation on the progression of carotid intima-media thickness and carotid arterial stiffness in older adults. Am J Clin Nutr. 2011 May; 93 (5): 941–49.

Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ, et al. Effects of homocysteine-lowering with folic acid plus vitamin B 12vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA. 2010 Jun 23; 303 (24): 2486–94.

House AA, Eliasziw M, Cattran DC, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA. 2010 Apr 28; 303 (16): 1603–9.

Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral Vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010 May 12; 303 (18): 1815–22.

Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA. 2002 Aug 14; 288 (6): 715–21.

Pittas AG, Chung M, Trikalinos T, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010 Mar 2; 152 (5): 307–14.

Grey A, Bolland MJ, Reid IR. Vitamin D supplementation. Arch Intern Med. 2010 Mar 22; 170 (6): 572–73.

Glerup H, Mikkelsen K, Poulsen L, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. J Internal Med. 2000; 247: 260–68.

Holick MF. Vitamin D: a millenium perspective. J Cell Biochem. 2003; 88: 296–307.

Reichrath J. The challenge resulting from positive and negative effects of sunlight: how much solar UV exposure is appropriate to balance between risks of vitamin D deficiency and skin cancer? Prog Biophys Mol Biol. 2006 Sep; 92 (1): 9–16.

Reusch J, Ackermann H, Badenhoop K. Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population. Horm Metab Res. 2009 May; 41 (5): 402–7.

Salamone LM, Dallal GE, Zantos D, et al. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women. Am J Clin Nutr. 1994 Jan; 59 (1): 80–86.

Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999; 69: 84256.

Holick MF. Sunlight Dilemma: risk of skin cancer or bone disease and muscle weakness. Lancet. 2001; 357: 46.

Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol. 2006 Feb; 54 (2): 301–17.

Wolpowitz D, Gilchrest BA. The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol. 2006 Feb; 54 (2): 301–17.

Lucas RM, Repacholi MH, McMichael AJ. Is the current public health message on UV exposure correct? Bull World Health Organ. 2006 Jun; 84 (6): 485–91.

Wharton JR, Cockerell CJ. The sun: a friend and enemy. Clin Dermatol. 1998 Jul – Aug; 16 (4): 415–19.

Porojnicu A, Robsahm TE, Berg JP, Moan J. Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J Steroid Biochem Mol Biol. 2007 Mar; 103 (3–5): 675–78.

Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colonand prostate cancer (Norway). Cancer Causes Control. 2004 Mar; 15 (2): 149–58.

Zhou W, Suk R, Liu G, et al. Vitamin D is associated with improved survival in earlystage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2005 Oct; 14 (10): 2303–9.

Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005 Feb 2; 97 (3):195–99.

Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004 Mar; 79 (3): 362–71.

Parry J, Sullivan E, Scott AC. Vitamin D sufficiency screening in preoperative pediatric orthopaedic patients. J Pediatr Orthop. 2011 Apr – May; 31 (3): 331–33.

Lee JH, Gadi R, Spertus JA, et al. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol. 2011 Mar 23.

Long AN, Ray MM, Nandikanti D, et al. Prevalence of 25-hydroxyvitamin D deficiency in an urban general internal medicine academic practice. Tenn Med. 2011 Jan; 104 (1): 45–6, 52.

Gómez-Alonso C, Naves-Díaz ML, Fernández-Martín JL, et al. Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int Suppl. 2003 Jun; (85): S44–48.

Rosen CJ. Vitamin D insufficiency. N Engl J Med. 2011 Jan 20; 364 (3): 248–54.

Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007 Jun; 92 (6): 2130–35.

Pramyothin P, Techasurungkul S, Lin J, et al. Vitamin D status and falls, frailty, and fractures among postmenopausal Japanese women living in Hawaii. Osteoporos Int. 2009 Nov; 20 (11): 1955–62.

Rosen CJ. Vitamin D insufficiency. N Engl J Med. 2011 Jan 20; 364 (3): 248–54.

Abrams SA. Vitamin D requirements in adolescents: what is the target? Am J Clin Nutr. 2011 Mar; 93 (3): 483–84.

Shaw N. Vitamin D and bone health in children. BMJ. 2011 Jan 25; 342: d192. doi: 10.1136/bmj.d192.

Schneider S, Kramer H. Who uses sunbeds? A systematic literature review of risk groups in developed countries. J Eur Acad Dermatol Venereol. 2010 Jun; 24 (6): 639–48.

Tangpricha V, Turner A, Spina C, et al. Tanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral density. Am J Clin Nutr. 2004; 80: 1645–49.

Treatment of vitamin D deficiency with UV light in patients with malabsorption syndromes: a case series. Photodermatol Photoimmunol Photomed. 2007 October; 23 (5): 179–85.

Heikkinen AM, Tuppurainen MT, Niskanen L, et al. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol. 1997 Nov; 137 (5): 495–502.

Tuppurainen M, Heikkinen AM, Penttilä I, Saarikoski S. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. Maturitas. 1995 Jun; 22 (1): 55–61.

Heikkinen AM, Tuppurainen MT, Niskanen L, et al. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol. 1997 Nov; 137 (5): 495–502.

Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer. 2004 Jan 1; 108 (1): 104–8.

Marshall TG. Vitamin D discovery outpaces FDA decision making. Bioessays. 2008 Feb; 30 (2): 173–82.

Meyer G, Köpke S. Vitamin D and falls. Information on harm is missing. BMJ. 2009 Oct 28; 339: b4395. doi: 10.1136/bmj.b4395.

Hsia J, Heiss G, Ren H, et al. 2007 Women’s Health Initiative. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007; 115: 846–54.